The human decatenation checkpoint.

@article{Deming2001TheHD,
  title={The human decatenation checkpoint.},
  author={Paula B. Deming and Cheryl A. Cistulli and Hui Zhao and Paul R. Graves and Helen Piwnica-Worms and Richard S. Paules and C. Stephen Downes and William K. Kaufmann},
  journal={Proceedings of the National Academy of Sciences of the United States of America},
  year={2001},
  volume={98 21},
  pages={12044-9}
}
Chromatid catenation is actively monitored in human cells, with progression from G(2) to mitosis being inhibited when chromatids are insufficiently decatenated. Mitotic delay was quantified in normal and checkpoint-deficient human cells during treatment with ICRF-193, a topoisomerase II catalytic inhibitor that prevents chromatid decatenation without producing topoisomerase-associated DNA strand breaks. Ataxia telangiectasia (A-T) cells, defective in DNA damage checkpoints, showed normal… CONTINUE READING
Highly Influential
This paper has highly influenced 16 other papers. REVIEW HIGHLY INFLUENTIAL CITATIONS
80 Citations
0 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 80 extracted citations

Similar Papers

Loading similar papers…